Flexion Therapeutics Inc (FLXN):企業の財務・戦略的SWOT分析

◆英語タイトル:Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH194959FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Flexion Therapeutics Inc (FLXN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Flexion Therapeutics Inc (Flexion) discovers, develops and commercializes pain therapies. The company’s pipeline is focused on indications that include osteoarthritis knee pain, OA pain , disease modification and acute-post operative pain. The company’s marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients facing with osteoarthritis-related knee pains. Flexion employs its proprietary microsphere technology to combine triamcinolone acetonide (TA) with a polylactic-co-glycolic acid (PLGA) matrix for formulating Zilretta. Its pipeline product candidate FX201 is being developed for treating pain caused from osteoarthritis of the knee and FX301, a NaV1.7 inhibitor in preclinical phase indicated for the treatment of acute-post operative pain. The company markets Zilretta in the US through its own sales and marketing organization and distributors. Flexion is headquartered in Burlington, Massachusetts, the US.

Flexion Therapeutics Inc Key Recent Developments

Nov 04,2020: Flexion Therapeutics reports third-quarter 2020 financial results and recent business highlights
Oct 13,2020: Flexion Therapeutics announces preliminary third-quarter 2020 ZILRETTA net sales of approximately $23.6 million
Aug 05,2020: Flexion Therapeutics reports second-quarter 2020 financial results and recent business highlights
Jul 14,2020: Flexion Therapeutics announces preliminary second-quarter 2020 ZILRETTA net sales
May 07,2020: Flexion Therapeutics reports first-quarter 2020 financial results and recent business highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Flexion Therapeutics Inc – Key Facts
Flexion Therapeutics Inc – Key Employees
Flexion Therapeutics Inc – Key Employee Biographies
Flexion Therapeutics Inc – Major Products and Services
Flexion Therapeutics Inc – History
Flexion Therapeutics Inc – Company Statement
Flexion Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Flexion Therapeutics Inc – Business Description
Flexion Therapeutics Inc – Corporate Strategy
Flexion Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Flexion Therapeutics Inc – Strengths
Flexion Therapeutics Inc – Weaknesses
Flexion Therapeutics Inc – Opportunities
Flexion Therapeutics Inc – Threats
Flexion Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Flexion Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 04, 2020: Flexion Therapeutics reports third-quarter 2020 financial results and recent business highlights
Oct 13, 2020: Flexion Therapeutics announces preliminary third-quarter 2020 ZILRETTA net sales of approximately $23.6 million
Aug 05, 2020: Flexion Therapeutics reports second-quarter 2020 financial results and recent business highlights
Jul 14, 2020: Flexion Therapeutics announces preliminary second-quarter 2020 ZILRETTA net sales
May 07, 2020: Flexion Therapeutics reports first-quarter 2020 financial results and recent business highlights
Mar 12, 2020: Flexion Therapeutics reports fourth-quarter and full-year 2019 financial results
Mar 11, 2020: Flexion Therapeutics names Melissa Layman Chief Commercial Officer
Dec 10, 2019: Flexion Therapeutics announces the retirement of Neil Bodick, M.D., Ph.D., chief scientific officer and company co-founder 2019
Nov 07, 2019: Flexion Therapeutics reports third-quarter 2019 financial results and recent business highlights
Sep 10, 2019: Flexion Therapeutics licences pain therapy from Xenon
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Flexion Therapeutics Inc, Key Facts
Flexion Therapeutics Inc, Key Employees
Flexion Therapeutics Inc, Key Employee Biographies
Flexion Therapeutics Inc, Major Products and Services
Flexion Therapeutics Inc, History
Flexion Therapeutics Inc, Subsidiaries
Flexion Therapeutics Inc, Key Competitors
Flexion Therapeutics Inc, Ratios based on current share price
Flexion Therapeutics Inc, Annual Ratios
Flexion Therapeutics Inc, Annual Ratios (Cont...1)
Flexion Therapeutics Inc, Interim Ratios
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Flexion Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Flexion Therapeutics Inc (FLXN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NetScout Systems Inc (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems Inc (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MYR Group Inc (MYRG):企業の財務・戦略的SWOT分析
    Summary MYR Group Inc (MYR Group) is an electrical contractor that provides specialty contracting services for industrial, commercial, and electrical infrastructure markets. The company operates substations, transmission lines, and distribution systems. It offers services such as distribution constr …
  • Autodesk Inc:戦略・SWOT・企業財務分析
    Autodesk Inc - Strategy, SWOT and Corporate Finance Report Summary Autodesk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Taerim Packaging Co., Ltd:企業の戦略・SWOT・財務情報
    Taerim Packaging Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Taerim Packaging Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Union Pacific Corporation:企業の戦略・SWOT・財務分析
    Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Union Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Rich Pharmaceuticals Inc (RCHA):企業の財務・戦略的SWOT分析
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Netcare Limited:企業の戦略・SWOT・財務情報
    Netcare Limited - Strategy, SWOT and Corporate Finance Report Summary Netcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Washington University in St Louis-製薬・医療分野:企業M&A・提携分析
    Summary Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range o …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務分析
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Prospect Medical Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prospect Medical Holdings Inc (PMHI) is a healthcare service provider that offers patient care services. The center offers medical, surgical and psychiatric services, among others. It owns and operates hospitals, clinics and physician networks that offers managed care services for HMO enrole …
  • Daelim Industrial Co Ltd:企業の戦略・SWOT・財務情報
    Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daelim Industrial Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Packaging Corporation of America:企業の戦略・SWOT・財務情報
    Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report Summary Packaging Corporation of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆